• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

121.48 +0.61 (+0.50%)
Official Closing Price Updated: 7:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 455,023
Open 121.10
Bid (Size) 102.23 (500)
Ask (Size) 126.83 (100)
Prev. Close 120.87
Today's Range 119.03 - 122.28
52wk Range 73.16 - 130.23
Shares Outstanding 55,137,429
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
April 06, 2026
From Glaukos Corporation
Via Business Wire
Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗
April 03, 2026
Via Chartmill

Performance

YTD
+9.7%
+9.7%
1 Month
+10.8%
+10.8%
3 Month
+1.3%
+1.3%
6 Month
+62.7%
+62.7%
1 Year
+27.3%
+27.3%

More News

Read More
News headline image
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
March 19, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
Glaukos Corp (NYSE:GKOS) Reports Record 2025 Sales but Shares Dip on Wider Loss, Conservative Outlook ↗
February 17, 2026
Via Chartmill
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
February 19, 2026
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
February 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos (GKOS) Q4 2025 Earnings Call Transcript ↗
February 17, 2026
Via The Motley Fool
Topics Earnings
News headline image
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
February 17, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Director Sells GKOS 15,000 Shares for $1.9 Million ↗
January 31, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
January 28, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
January 20, 2026
From Glaukos Corporation
Via Business Wire
These stocks are moving in today's after hours session ↗
January 13, 2026
Via Chartmill
News headline image
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
January 13, 2026
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
December 16, 2025
From Glaukos Corporation
Via Business Wire
News headline image
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗
November 06, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Glaukos Announces Participation in Upcoming Investor Conferences
November 03, 2025
From Glaukos Corporation
Via Business Wire
News headline image
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗
October 30, 2025
Via The Motley Fool
News headline image
Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗
October 30, 2025
Via The Motley Fool
Topics Earnings
News headline image
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗
October 30, 2025
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
October 30, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 30, 2025
Via Benzinga
News headline image
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗
October 30, 2025
Via Benzinga

Frequently Asked Questions

Is Glaukos Corporation Common Stock publicly traded?
Yes, Glaukos Corporation Common Stock is publicly traded.
What exchange does Glaukos Corporation Common Stock trade on?
Glaukos Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Glaukos Corporation Common Stock?
The ticker symbol for Glaukos Corporation Common Stock is GKOS on the New York Stock Exchange
What is the current price of Glaukos Corporation Common Stock?
The current price of Glaukos Corporation Common Stock is 121.48
When was Glaukos Corporation Common Stock last traded?
The last trade of Glaukos Corporation Common Stock was at 04/24/26 07:00 PM ET
What is the market capitalization of Glaukos Corporation Common Stock?
The market capitalization of Glaukos Corporation Common Stock is 6.70B
How many shares of Glaukos Corporation Common Stock are outstanding?
Glaukos Corporation Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap